- 2018
-
What's on? - 20.04.2018
Wednesday, April 25, 2018: World Malaria Day
Caused by a parasite of the genus Plasmodium, malaria is transmitted to humans through bites from the female Anopheles mosquito. It can also be transmitted via blood transfusion or from mother to child at the end of pregnancy. [1] In 2016, the number of deaths caused by malaria was estimated at 445,000. Half of the […]
-
Press releases - 19.04.2018
New gene therapy success in beta thalassemia: 22 patients treated in France, United States, Thailand and Australia
In an article in the New England Journal of Medicine published on April 19, the intermediate results of a clinical trial (HGB-205) led by Pr. Marina Cavazzana and her teams at the Necker-Enfants malades hospital AP-HP in collaboration with the Imagine Institute (AP-HP/Inserm/Paris Descartes University) as well as those of an international multicenter trial (HGB-204) conducted in the United States, Thailand and Australia, show that gene therapy is effective in improving the state of health or curing patients with beta thalassemia. These two clinical trials have used the same therapeutic vector “LentiGlobin”, developed at Harvard University in Boston and at the CEA in Fontenay-aux-Roses by Pr. Philippe Leboulch, in collaboration with the American company bluebird bio, for which he is the founder.
-
Press releases - 19.04.2018
Preserving Kidneys to Avoid Dialysis
How can we preserve renal function in people with a chronic kidney disease? Can dialysis be avoided or delayed? To answer these questions and many others, Inserm and Université Paris-Sud have set up the CKD-REIN1 cohort study, led by Bénédicte Stengel. Today it has produced its first results. According to the study, conducted with more than 3,000 patients, several priorities may improve the management of kidney disease. These priorities include improving blood pressure monitoring, providing more nutritional advice, and raising awareness among patients and health care professionals about the risk of medicine overdose.
-
Press releases - 18.04.2018
Immunization Week 2018
The thirteenth annual World Immunization Week will take place from April 23 to 29, 2018. The campaign, created by the World Health Organization (WHO), undertakes to raise awareness about the stakes of vaccine protection.
-
What's on? - 18.04.2018
Immunization Week 2018
The thirteenth annual World Immunization Week will take place from April 23 to 29, 2018. The campaign, created by the World Health Organization (WHO), undertakes to raise awareness about the stakes of vaccine protection. This year, WHO is focusing on the importance of immunizing every child to “prevent the relevant diseases and protect their lives.” […]
-
Press releases - 11.04.2018
Achievements in Innovation: Inserm Sets Itself Apart Once Again Through its Momentum and Results
The respective classifications of the European Patent Office (EPO) and France’s National Industrial Property Institute (INPI), which have just published their annual rankings for 2017, have confirmed Inserm’s ability to innovate. Inserm placed first among patent applicants in the pharmaceutical sector for the second year in a row, yet again leading the rankings of European applicants in this sector, ahead of both industrial manufacturers and academic institutions. Furthermore, the Institute was in 30th place – having moved up five places – in the INPI’s “patents in all fields” ranking, confirming its research teams’ excellence and productivity in innovation.
-
Press releases - 10.04.2018
Hepatitis C: a novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques that can be “decentralized”, in other words accessed by populations and countries with limited resources. Scientists from the Institut Pasteur and Inserm, in collaboration with the company genedrive, have developed and validated a rapid, reliable, point-of-care HCV assay. This new screening assay means that patients can begin treatment for the disease as soon as they are diagnosed. The results have been published in the journal Gut on April 4th, 2018.
-
Press releases - 10.04.2018
Parkinson’s Disease: Acute Risk in Agricultural Areas
À l’occasion de la journée mondiale Parkinson, une étude publiée dans le Bulletin épidémiologique hebdomadaire (BEH) suggère un risque plus important de développer la maladie chez les personnes qui vivent dans des cantons agricoles.
-
What's on? - 10.04.2018
Parkinson’s Disease: Acute Risk in Agricultural Areas
A study published in the Bulletin épidémiologique hebdomadaire (BEH – Weekly Epidemiology Report) for World Parkinson’s Day suggests that the risk of developing the disease is higher in people who live in farming districts. A national study, published in the BEH devoted to the epidemiology of Parkinson’s disease in France, is researching the incidence of […]
-
Press releases - 04.04.2018
Artificial Intelligence to serve health research: Inserm and Owkin join forces
Accelerate artificial intelligence research to benefit health: such is the shared objective underpinning the agreement signed by Inserm and the start-up Owkin, specialized in machine learning applied to biological and medical research. The tools developed by Owkin, combined with the mass of health data either produced or used by Inserm, will lead to the development of disruptive innovations unprecedented in the field of medical and clinical research.